Literature DB >> 17898988

The enteroinsular axis may mediate the diabetogenic effects of TCF7L2 polymorphisms.

M A Nauck1, J J Meier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17898988     DOI： 10.1007/s00125-007-0832-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  32 in total

1.  TCF7L2 and type 2 diabetes--we WNT to know.

Authors:  U Smith
Journal:  Diabetologia       Date:  2006-11-11       Impact factor: 10.122

2.  Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys.

Authors:  C Marzi; C Huth; M Kolz; H Grallert; C Meisinger; H-E Wichmann; W Rathmann; C Herder; T Illig
Journal:  Horm Metab Res       Date:  2007-01       Impact factor: 2.936

3.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

Authors:  Struan F A Grant; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Andrei Manolescu; Jesus Sainz; Agnar Helgason; Hreinn Stefansson; Valur Emilsson; Anna Helgadottir; Unnur Styrkarsdottir; Kristinn P Magnusson; G Bragi Walters; Ebba Palsdottir; Thorbjorg Jonsdottir; Thorunn Gudmundsdottir; Arnaldur Gylfason; Jona Saemundsdottir; Robert L Wilensky; Muredach P Reilly; Daniel J Rader; Yu Bagger; Claus Christiansen; Vilmundur Gudnason; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

4.  TCF7L2 variation predicts hyperglycemia incidence in a French general population: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.

Authors:  Stéphane Cauchi; David Meyre; Hélène Choquet; Christian Dina; Catherine Born; Michel Marre; Beverley Balkau; Philippe Froguel
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

5.  Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women.

Authors:  Julian Munoz; Kerry H Lok; Barbara A Gower; Jose R Fernandez; Gary R Hunter; Cristina Lara-Castro; Maria De Luca; W Timothy Garvey
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

6.  Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.

Authors:  Stéphane Cauchi; David Meyre; Christian Dina; Hélène Choquet; Chantal Samson; Sophie Gallina; Beverley Balkau; Guillaume Charpentier; François Pattou; Volodymyr Stetsyuk; Raphaël Scharfmann; Bart Staels; Gema Frühbeck; Philippe Froguel
Journal:  Diabetes       Date:  2006-10       Impact factor: 9.461

7.  Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells.

Authors:  Elizabeth J Abraham; Colin A Leech; Julia C Lin; Henryk Zulewski; Joel F Habener
Journal:  Endocrinology       Date:  2002-08       Impact factor: 4.736

8.  Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.

Authors:  Loredana Farilla; Angela Bulotta; Boaz Hirshberg; Sergio Li Calzi; Nasif Khoury; Houtan Noushmehr; Cristina Bertolotto; Umberto Di Mario; David M Harlan; Riccardo Perfetti
Journal:  Endocrinology       Date:  2003-08-28       Impact factor: 4.736

9.  The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.

Authors:  Lise L Kjems; Jens J Holst; Aage Vølund; Sten Madsbad
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

10.  Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.

Authors:  S A Schäfer; O Tschritter; F Machicao; C Thamer; N Stefan; B Gallwitz; J J Holst; J M Dekker; L M 't Hart; L M t'Hart; G Nijpels; T W van Haeften; H U Häring; A Fritsche
Journal:  Diabetologia       Date:  2007-07-28       Impact factor: 10.122
View more
  9 in total

Review 1.  The contribution of enteroinsular hormones to the pathogenesis of type 2 diabetes mellitus.

Authors:  Dima L Diab; David A D'Alessio
Journal:  Curr Diab Rep       Date:  2010-06       Impact factor: 4.810

Review 2.  Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus.

Authors:  Devjit Tripathy; Alberto O Chavez
Journal:  Curr Diab Rep       Date:  2010-06       Impact factor: 4.810

Review 3.  Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?

Authors:  Juris J Meier; Michael A Nauck
Journal:  Diabetes       Date:  2010-05       Impact factor: 9.461

4.  The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.

Authors:  K Pilgaard; C B Jensen; J H Schou; V Lyssenko; L Wegner; C Brøns; T Vilsbøll; T Hansen; S Madsbad; J J Holst; A Vølund; P Poulsen; L Groop; O Pedersen; A A Vaag
Journal:  Diabetologia       Date:  2009-03-14       Impact factor: 10.122

5.  Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.

Authors:  Luan Shu; Aleksey V Matveyenko; Julie Kerr-Conte; Jae-Hyoung Cho; Christopher H S McIntosh; Kathrin Maedler
Journal:  Hum Mol Genet       Date:  2009-04-21       Impact factor: 6.150

Review 6.  TCF7L2 genetic defect and type 2 diabetes.

Authors:  Stéphane Cauchi; Philippe Froguel
Journal:  Curr Diab Rep       Date:  2008-04       Impact factor: 4.810

7.  COUP-TFII controls mouse pancreatic β-cell mass through GLP-1-β-catenin signaling pathways.

Authors:  Marie Boutant; Oscar Henrique Pereira Ramos; Cécile Tourrel-Cuzin; Jamileh Movassat; Anissa Ilias; David Vallois; Julien Planchais; Jean-Paul Pégorier; Frans Schuit; Patrice X Petit; Pascale Bossard; Kathrin Maedler; Anne Grapin-Botton; Mireille Vasseur-Cognet
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

8.  The T-allele of TCF7L2 rs7903146 associates with a reduced compensation of insulin secretion for insulin resistance induced by 9 days of bed rest.

Authors:  Amra C Alibegovic; Mette P Sonne; Lise Højbjerre; Torben Hansen; Oluf Pedersen; Gerrit van Hall; Jens J Holst; Bente Stallknecht; Flemming Dela; Allan Vaag
Journal:  Diabetes       Date:  2010-01-27       Impact factor: 9.461

9.  Serum Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) in association with the Risk of Gestational Diabetes: A Prospective Case-Control Study.

Authors:  Maryam Mosavat; Siti Zawiah Omar; Sajad Jamalpour; Peng Chiong Tan
Journal:  J Diabetes Res       Date:  2020-01-29       Impact factor: 4.011
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.